Loading
DistillerSR
DistillerSR Inc., based in Ottawa, Ontario, is a leader in AI-enabled literature review automation software and enterprise evidence management solutions. Founded in 2008, the company serves a wide range of sectors, including healthcare, academia, government, and commercial organizations. DistillerSR rebranded from Evidence Partners in September 2022 to highlight its flagship platform, DistillerSR™, which automates the literature review process from search referencing to reporting. The DistillerSR platform offers features such as AI-driven screening, configurable workflows, and real-time collaboration tools. In February 2024, the company introduced Smart Evidence Extraction (SEE)™, a GenAI solution designed to enhance data extraction accuracy for literature reviews. DistillerSR also provides managed services for the entire literature review lifecycle and specialized software modules for systematic reviews, clinical evaluation reports, and more. With a client base that includes over 300 leading pharmaceutical and medical device companies, DistillerSR is recognized for delivering transparent and audit-ready results efficiently.
Funding
Every round, secondary, debt facility or acquisition involving DistillerSR that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—